Market Segmentation
Formulation Insights (Revenue, USD Mn, 2026 - 2033)
- Tablet
- Liquid Suspension
Indication Insights (Revenue, USD Mn, 2026 - 2033)
- Gastric Ulcers
- Duodenal Ulcers
- Gastro Esophageal Reflux Disease (GERD)
- Others
Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
State Insights (Revenue, USD Mn, 2026 - 2033)
- Illinois
- Texas
- New York
- California
- Others
